Analyst Reco. Chimerix, Inc. Börse Stuttgart

Equities

CXF

US16934W1062

Market Closed - Börse Stuttgart Other stock markets 04:36:07 03/07/2024 pm IST			5-day change	1st Jan Change
0.786 ^EUR	-0.63%		-5.72%	-2.90%

01/05	Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024
01/05	Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Baird Initiates Chimerix at Outperform With $7 Price Target	23/23/23	MT
Capital One Starts Chimerix at Overweight With $7 Price Target	07/22/07	MT
Wedbush Cuts Price Target on Chimerix to $6 From $8, Citing ONC201 Estimated Launch, Keeps Outperform Rating	09/22/09	MT
HC Wainwright Adjusts Price Target on Chimerix to $11 From $24, Reiterates Buy Rating	17/22/17	MT
Cowen Lowers Price Target for Chimerix to $10 From $18, Maintains Outperform Rating	17/22/17	MT
Wedbush Adjusts Chimerix Price Target to $8 From $14, Maintains Outperform Rating	16/22/16	MT
HC Wainwright Adjusts Chimerix's Price Target to $24 From $21, Keeps Buy Rating	22/21/22	MT
Wedbush Trims Price Target on Chimerix to $14 From $15, Keeps Outperform Rating	23/21/23	MT
Wedbush Trims Price Target for Chimerix to $14 From $15, Maintains Outperform Rating	23/21/23	MT
HC Wainwright Adjusts Chimerix PT to $21 From $19, Maintains Buy Rating	22/21/22	MT
Chimerix Says ONC201 Glioma Treatment Candidate Showed 20% Response Rate in Patient Sample From Studies	04/21/04	MT
CHIMERIX : HC Wainwright Adjusts Chimerix' Price Target to $19 From $18, Keeps Buy Rating	07/21/07	MT
CHIMERIX : Wedbush Adjusts Price Target for Chimerix to $15 From $14, Maintains Outperform Rating	07/21/07	MT
CHIMERIX : Maxim Group Initiates Chimerix at Buy Rating With $20 Price Target	29/21/29	MT
CHIMERIX : Jefferies Starts Chimerix at Buy With $21 Price Target	31/21/31	MT
CHIMERIX : Wedbush Starts Chimerix at Outperform With $14 Price Target	31/21/31	MT
CHIMERIX : HC Wainwright Adjusts Chimerix's Price Target to $16 From $7, Keeps at Buy	11/21/11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer